Jennifer Luchavez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jennifer Luchavez has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Chris Drakeley
Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom
4 shared publications - David Bell
Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
4 shared publications - Fe Esperanza J. Espino
Department of Parasitology, Research Institute for Tropical Medicine, Muntinlupa, Philippines
4 shared publications - Julius Clemence R. Hafalla
Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
4 shared publications - Michelle Louise Gatton
Faculty of Health, School of Public Health and Social Work, Queensland University of Technology, Kelvin Grove, Australia
4 shared publications - Peter L. Chiodini
Department of Clinical Parasitology, Hospital for Tropical Diseases, London, UK
4 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (5) , 1036-1039
Absence of Plasmodium falciparum Histidine-Rich Protein 2 and 3 (Pfhrp2/3) Gene Deletions in Rizal, Palawan, the Philippines
: Microscopy and rapid diagnostic tests (RDTs) are used in the Philippines as the gold standard for malaria diagnosis. However, parasites evading RDT detection have recently emerged in other settings as a result of deletions in Plasmodium falciparum histidine-rich protein genes ( pfhrp2 and pfhrp3 ). Failure to detect and treat individuals carrying these deletions may result in increased malaria transmission and hinder elimination efforts. In addition to the implications for malaria elimination efforts, we emphasize that false-negative RDT results caused by pfhrp2/3 deletions pose a critical risk to patient outcomes, as individuals with active P. falciparum infections may go untreated. Sixty-three samples collected from Palawan, the Philippines, were interrogated for the presence of Plasmodium isolates and pfhrp deletions. All 63 samples were microscopically positive for P. falciparum . Although only 27 (43%) were positive for RDTs, all samples were confirmed free of pfhrp2 and pfhrp3 deletions by nested polymerase chain reaction (PCR) tests. RDT false negatives in the study were most likely caused by low parasite densities. Incorporating molecular monitoring of histidine-rich protein 2 deletions into routine malaria surveillance would improve assessments of the performance of the current RDTs and help strengthen strategies toward malaria elimination by 2030.
- 4 November 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (5) , 1036-1039
Open AccessAbsence of Plasmodium falciparum Histidine-Rich Protein 2 and 3 (Pfhrp2/3) Gene Deletions in Rizal, Palawan, the Philippines
: Microscopy and rapid diagnostic tests (RDTs) are used in the Philippines as the gold standard for malaria diagnosis. However, parasites evading RDT detection have recently emerged in other settings as a result of deletions in Plasmodium falciparum histidine-rich protein genes ( pfhrp2 and pfhrp3 ). Failure to detect and treat individuals carrying these deletions may result in increased malaria transmission and hinder elimination efforts. In addition to the implications for malaria elimination efforts, we emphasize that false-negative RDT results caused by pfhrp2/3 deletions pose a critical risk to patient outcomes, as individuals with active P. falciparum infections may go untreated. Sixty-three samples collected from Palawan, the Philippines, were interrogated for the presence of Plasmodium isolates and pfhrp deletions. All 63 samples were microscopically positive for P. falciparum . Although only 27 (43%) were positive for RDTs, all samples were confirmed free of pfhrp2 and pfhrp3 deletions by nested polymerase chain reaction (PCR) tests. RDT false negatives in the study were most likely caused by low parasite densities. Incorporating molecular monitoring of histidine-rich protein 2 deletions into routine malaria surveillance would improve assessments of the performance of the current RDTs and help strengthen strategies toward malaria elimination by 2030.
- Open Access
- 20 May 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 37, 100792
Analytical approaches for antimalarial antibody responses to confirm historical and recent malaria transmission: an example from the Philippines
- 20 May 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 37, 100792
Open AccessAnalytical approaches for antimalarial antibody responses to confirm historical and recent malaria transmission: an example from the Philippines
- Open Access
- 18 January 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (3) , 968-978
Enhanced Health Facility Surveys to Support Malaria Control and Elimination across Different Transmission Settings in the Philippines
Following substantial progress in malaria control in the Philippines, new surveillance approaches are needed to identify and target residual malaria transmission. This study evaluated an enhanced surveillance approach using rolling cross-sectional surveys of all health facility attendees augmented with molecular diagnostics and geolocation. Facility surveys were carried out in three sites representing different transmission intensities: Morong, Bataan (pre-elimination), Abra de Ilog, Occidental Mindoro (stable medium risk), and Rizal, Palawan (high risk, control). Only one rapid diagnostic test (RDT)–positive infection and no PCR confirmed infections were found in Bataan and Occidental Mindoro, suggesting the absence of transmission. In Palawan, the inclusion of all health facility attendees, regardless of symptoms, and use of molecular diagnostics identified 313 infected individuals in addition to 300 cases identified by routine screening of febrile patients with the RDT or microscopy. Of these, the majority (313/613) were subpatent infections and only detected using molecular methods. Simultaneous collection of GPS coordinates on tablet-based applications allowed real-time mapping of malaria infections. Risk factor analysis showed higher risks in children and indigenous groups, with bed net use having a protective effect. Subpatent infections were more common in men and older age-groups. Overall, malaria risks were not associated with participants’ classification, and some of the non-patient clinic attendees reported febrile illnesses (1.9%, 26/1,369), despite not seeking treatment, highlighting the widespread distribution of infection in communities. Together, these data illustrate the utility of health facility–based surveys to augment surveillance data to increase the probability of detecting infections in the wider community.
- 18 January 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (3) , 968-978
Open AccessEnhanced Health Facility Surveys to Support Malaria Control and Elimination across Different Transmission Settings in the Philippines
Following substantial progress in malaria control in the Philippines, new surveillance approaches are needed to identify and target residual malaria transmission. This study evaluated an enhanced surveillance approach using rolling cross-sectional surveys of all health facility attendees augmented with molecular diagnostics and geolocation. Facility surveys were carried out in three sites representing different transmission intensities: Morong, Bataan (pre-elimination), Abra de Ilog, Occidental Mindoro (stable medium risk), and Rizal, Palawan (high risk, control). Only one rapid diagnostic test (RDT)–positive infection and no PCR confirmed infections were found in Bataan and Occidental Mindoro, suggesting the absence of transmission. In Palawan, the inclusion of all health facility attendees, regardless of symptoms, and use of molecular diagnostics identified 313 infected individuals in addition to 300 cases identified by routine screening of febrile patients with the RDT or microscopy. Of these, the majority (313/613) were subpatent infections and only detected using molecular methods. Simultaneous collection of GPS coordinates on tablet-based applications allowed real-time mapping of malaria infections. Risk factor analysis showed higher risks in children and indigenous groups, with bed net use having a protective effect. Subpatent infections were more common in men and older age-groups. Overall, malaria risks were not associated with participants’ classification, and some of the non-patient clinic attendees reported febrile illnesses (1.9%, 26/1,369), despite not seeking treatment, highlighting the widespread distribution of infection in communities. Together, these data illustrate the utility of health facility–based surveys to augment surveillance data to increase the probability of detecting infections in the wider community.
- Open Access
Enhanced health facility surveys to support malaria control and elimination across different transmission settings in The Philippines
Following substantial progress in malaria control in the Philippines, new surveillance approaches are needed to identify and target residual malaria transmission. This study evaluated an enhanced surveillance approach using rolling cross-sectional surveys of all health facility attendees augmented with molecular diagnostics and geolocation. Facility surveys were carried out in 3 sites representing different transmission intensities: Morong, Bataan (pre-elimination), Abra de Ilog, Occidental Mindoro (stable-medium risk) and Rizal, Palawan (high risk, control). Only 1 RDT positive infection and no PCR confirmed infections were found in Bataan and Occidental Mindoro suggesting the absence of transmission. In Rizal, inclusion of all health facility attendees, regardless of symptoms, and use of molecular diagnostics identified an additional 313 infected individuals in addition to 300 cases identified by routine screening of febrile patients with RDT or microscopy. Of these, the majority (313/613) were subpatent infections and only detected using molecular methods. Simultaneous collection of GPS coordinates on tablet-based applications allowed real-time mapping of malaria infections. Risk factor analysis showed higher risks in children and indigenous groups, with bednet use having a protective effect. Subpatent infections were more common in men and older age groups. Overall, malaria risks were not associated with patient status and some of non-patient clinic attendees reported febrile illnesses (1.9%, 26/1369) despite not seeking treatment highlighting the widespread distribution of infection in communities. Together, these data illustrate the utility of health-facility based surveys to augment surveillance data to increase the probability of detecting infections in the wider community.
Open AccessEnhanced health facility surveys to support malaria control and elimination across different transmission settings in The Philippines
Following substantial progress in malaria control in the Philippines, new surveillance approaches are needed to identify and target residual malaria transmission. This study evaluated an enhanced surveillance approach using rolling cross-sectional surveys of all health facility attendees augmented with molecular diagnostics and geolocation. Facility surveys were carried out in 3 sites representing different transmission intensities: Morong, Bataan (pre-elimination), Abra de Ilog, Occidental Mindoro (stable-medium risk) and Rizal, Palawan (high risk, control). Only 1 RDT positive infection and no PCR confirmed infections were found in Bataan and Occidental Mindoro suggesting the absence of transmission. In Rizal, inclusion of all health facility attendees, regardless of symptoms, and use of molecular diagnostics identified an additional 313 infected individuals in addition to 300 cases identified by routine screening of febrile patients with RDT or microscopy. Of these, the majority (313/613) were subpatent infections and only detected using molecular methods. Simultaneous collection of GPS coordinates on tablet-based applications allowed real-time mapping of malaria infections. Risk factor analysis showed higher risks in children and indigenous groups, with bednet use having a protective effect. Subpatent infections were more common in men and older age groups. Overall, malaria risks were not associated with patient status and some of non-patient clinic attendees reported febrile illnesses (1.9%, 26/1369) despite not seeking treatment highlighting the widespread distribution of infection in communities. Together, these data illustrate the utility of health-facility based surveys to augment surveillance data to increase the probability of detecting infections in the wider community.
- Open Access
- 2 December 2019
- Published by Springer Nature in Malaria Journal
- Vol. 18 (1) , 1-15
A review of the WHO malaria rapid diagnostic test product testing programme (2008–2018): performance, procurement and policy
Malaria rapid diagnostic tests (RDTs) emerged in the early 1990s into largely unregulated markets, and uncertain field performance was a major concern for the acceptance of tests for malaria case management. This, combined with the need to guide procurement decisions of UN agencies and WHO Member States, led to the creation of an independent, internationally coordinated RDT evaluation programme aiming to provide comparative performance data of commercially available RDTs. Products were assessed against Plasmodium falciparum and Plasmodium vivax samples diluted to two densities, along with malaria-negative samples from healthy individuals, and from people with immunological abnormalities or non-malarial infections. Three measures were established as indicators of performance, (i) panel detection score (PDS) determined against low density panels prepared from P. falciparum and P. vivax wild-type samples, (ii) false positive rate, and (iii) invalid rate, and minimum criteria defined. Over eight rounds of the programme, 332 products were tested. Between Rounds 1 and 8, substantial improvements were seen in all performance measures. The number of products meeting all criteria increased from 26.8% (11/41) in Round 1, to 79.4% (27/34) in Round 8. While products submitted to further evaluation rounds under compulsory re-testing did not show improvement, those voluntarily resubmitted showed significant increases in P. falciparum (p = 0.002) and P. vivax PDS (p < 0.001), with more products meeting the criteria upon re-testing. Through this programme, the differentiation of products based on comparative performance, combined with policy changes has been influential in the acceptance of malaria RDTs as a case-management tool, enabling a policy of parasite-based diagnosis prior to treatment. Publication of product testing results has produced a transparent market allowing users and procurers to clearly identify appropriate products for their situation, and could form a model for introduction of other, broad-scale diagnostics.
- 2 December 2019
- Published by Springer Nature in Malaria Journal
- Vol. 18 (1) , 1-15
Open AccessA review of the WHO malaria rapid diagnostic test product testing programme (2008–2018): performance, procurement and policy
Malaria rapid diagnostic tests (RDTs) emerged in the early 1990s into largely unregulated markets, and uncertain field performance was a major concern for the acceptance of tests for malaria case management. This, combined with the need to guide procurement decisions of UN agencies and WHO Member States, led to the creation of an independent, internationally coordinated RDT evaluation programme aiming to provide comparative performance data of commercially available RDTs. Products were assessed against Plasmodium falciparum and Plasmodium vivax samples diluted to two densities, along with malaria-negative samples from healthy individuals, and from people with immunological abnormalities or non-malarial infections. Three measures were established as indicators of performance, (i) panel detection score (PDS) determined against low density panels prepared from P. falciparum and P. vivax wild-type samples, (ii) false positive rate, and (iii) invalid rate, and minimum criteria defined. Over eight rounds of the programme, 332 products were tested. Between Rounds 1 and 8, substantial improvements were seen in all performance measures. The number of products meeting all criteria increased from 26.8% (11/41) in Round 1, to 79.4% (27/34) in Round 8. While products submitted to further evaluation rounds under compulsory re-testing did not show improvement, those voluntarily resubmitted showed significant increases in P. falciparum (p = 0.002) and P. vivax PDS (p < 0.001), with more products meeting the criteria upon re-testing. Through this programme, the differentiation of products based on comparative performance, combined with policy changes has been influential in the acceptance of malaria RDTs as a case-management tool, enabling a policy of parasite-based diagnosis prior to treatment. Publication of product testing results has produced a transparent market allowing users and procurers to clearly identify appropriate products for their situation, and could form a model for introduction of other, broad-scale diagnostics.
- Open Access
- 6 December 2014
- Published by Springer Nature in Malaria Journal
- Vol. 13 (1) , 480
Circulating antibodies against Plasmodium falciparum histidine-rich proteins 2 interfere with antigen detection by rapid diagnostic tests
Rapid diagnostic tests (RDTs) for detection of Plasmodium falciparum infection that target P. falciparum histidine-rich protein 2 (PfHRP2), a protein that circulates in the blood of patients infected with this species of malaria, are widely used to guide case management. Understanding determinants of PfHRP2 availability in circulation is therefore essential to understanding the performance of PfHRP2-detecting RDTs.
- 6 December 2014
- Published by Springer Nature in Malaria Journal
- Vol. 13 (1) , 480
Open AccessCirculating antibodies against Plasmodium falciparum histidine-rich proteins 2 interfere with antigen detection by rapid diagnostic tests
Rapid diagnostic tests (RDTs) for detection of Plasmodium falciparum infection that target P. falciparum histidine-rich protein 2 (PfHRP2), a protein that circulates in the blood of patients infected with this species of malaria, are widely used to guide case management. Understanding determinants of PfHRP2 availability in circulation is therefore essential to understanding the performance of PfHRP2-detecting RDTs.
- Open Access
- 6 December 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 406
Malaria rapid diagnostic test transport and storage conditions in Burkina Faso, Senegal, Ethiopia and the Philippines
As more point of care diagnostics become available, the need to transport and store perishable medical commodities to remote locations increases. As with other diagnostics, malaria rapid diagnostic tests (RDTs) must be highly reliable at point of use, but exposure to adverse environmental conditions during distribution has the potential to degrade tests and accuracy. In remote locations, poor quality diagnostics and drugs may have significant negative health impact that is not readily detectable by routine monitoring. This study assessed temperature and humidity throughout supply chains used to transport and store health commodities, such as RDTs.
- 6 December 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 406
Open AccessMalaria rapid diagnostic test transport and storage conditions in Burkina Faso, Senegal, Ethiopia and the Philippines
As more point of care diagnostics become available, the need to transport and store perishable medical commodities to remote locations increases. As with other diagnostics, malaria rapid diagnostic tests (RDTs) must be highly reliable at point of use, but exposure to adverse environmental conditions during distribution has the potential to degrade tests and accuracy. In remote locations, poor quality diagnostics and drugs may have significant negative health impact that is not readily detectable by routine monitoring. This study assessed temperature and humidity throughout supply chains used to transport and store health commodities, such as RDTs.
- Open Access
- 24 October 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 352
Developing standards for malaria microscopy: external competency assessment for malaria microscopists in the Asia-Pacific
Background: Malaria diagnosis has received renewed interest in recent years, associated with the increasing accessibility of accurate diagnosis through the introduction of rapid diagnostic tests and new World Health Organization guidelines recommending parasite-based diagnosis prior to anti-malarial therapy. However, light microscopy, established over 100 years ago and frequently considered the reference standard for clinical diagnosis, has been neglected in control programmes and in the malaria literature and evidence suggests field standards are commonly poor. Microscopy remains the most accessible method for parasite quantitation, for drug efficacy monitoring, and as a reference of assessing other diagnostic tools. This mismatch between quality and need highlights the importance of the establishment of reliable standards and procedures for assessing and assuring quality. This paper describes the development, function and impact of a multi-country microscopy external quality assurance network set up for this purpose in Asia. Methods: Surveys were used for key informants and past participants for feedback on the quality assurance programme. Competency scores for each country from 14 participating countries were compiled for analyses using paired sample t-tests. In-depth interviews were conducted with key informants including the programme facilitators and national level microscopists. Results: External assessments and limited retraining through a formalized programme based on a reference slide bank has demonstrated an increase in standards of competence of senior microscopists over a relatively short period of time, at a potentially sustainable cost. The network involved in the programme now exceeds 14 countries in the Asia-Pacific, and the methods are extended to other regions. Conclusions: While the impact on national programmes varies, it has translated in some instances into a strengthening of national microscopy standards and offers a possibility both for supporting revival of national microcopy programmes, and for the development of globally recognized standards of competency needed both for patient management and field research.
- 24 October 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 352
Open AccessDeveloping standards for malaria microscopy: external competency assessment for malaria microscopists in the Asia-Pacific
Background: Malaria diagnosis has received renewed interest in recent years, associated with the increasing accessibility of accurate diagnosis through the introduction of rapid diagnostic tests and new World Health Organization guidelines recommending parasite-based diagnosis prior to anti-malarial therapy. However, light microscopy, established over 100 years ago and frequently considered the reference standard for clinical diagnosis, has been neglected in control programmes and in the malaria literature and evidence suggests field standards are commonly poor. Microscopy remains the most accessible method for parasite quantitation, for drug efficacy monitoring, and as a reference of assessing other diagnostic tools. This mismatch between quality and need highlights the importance of the establishment of reliable standards and procedures for assessing and assuring quality. This paper describes the development, function and impact of a multi-country microscopy external quality assurance network set up for this purpose in Asia. Methods: Surveys were used for key informants and past participants for feedback on the quality assurance programme. Competency scores for each country from 14 participating countries were compiled for analyses using paired sample t-tests. In-depth interviews were conducted with key informants including the programme facilitators and national level microscopists. Results: External assessments and limited retraining through a formalized programme based on a reference slide bank has demonstrated an increase in standards of competence of senior microscopists over a relatively short period of time, at a potentially sustainable cost. The network involved in the programme now exceeds 14 countries in the Asia-Pacific, and the methods are extended to other regions. Conclusions: While the impact on national programmes varies, it has translated in some instances into a strengthening of national microscopy standards and offers a possibility both for supporting revival of national microcopy programmes, and for the development of globally recognized standards of competency needed both for patient management and field research.
- Open Access
- 29 September 2011
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1) , 286
Laboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management
Background: Malaria rapid diagnostic tests (RDTs) are now widely used for prompt on-site diagnosis in remote endemic areas where reliable microscopy is absent. Aberrant results, whereby negative test results occur at high parasite densities, have been variously reported for over a decade and have led to questions regarding the reliability of the tests in clinical use. Methods: In the first trial, serial dilutions of recombinant HRP2 antigen were tested on an HRP2-detectiing RDT. In a second trial, serial dilutions of culture-derived Plasmodium falciparum parasites were tested against three HRP2-detecting RDTs. Results: A prozone-like effect occurred in RDTs at a high concentration of the target antigen, histidine-rich protein-2 (above 15,000 ng/ml), a level that corresponds to more than 312000 parasites per μL. Similar results were noted on three RDT products using dilutions of cultured parasites up to a parasite density of 25%. While reduced line intensity was observed, no false negative results occurred. Conclusions: These results suggest that false-negative malaria RDT results will rarely occur due to a prozone-like effect in high-density infections, and other causes are more likely. However, RDT line intensity is poorly indicative of parasite density in high-density infections and RDTs should, therefore, not be considered quantitative. Immediate management of suspected severe malaria should rely on clinical assessment or microscopy. Evaluation against high concentrations of antigen should be considered in malaria RDT product development and lot-release testing, to ensure that very weak or false negative results will not occur at antigen concentrations that might be seen clinically.
- 29 September 2011
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1) , 286
Open AccessLaboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management
Background: Malaria rapid diagnostic tests (RDTs) are now widely used for prompt on-site diagnosis in remote endemic areas where reliable microscopy is absent. Aberrant results, whereby negative test results occur at high parasite densities, have been variously reported for over a decade and have led to questions regarding the reliability of the tests in clinical use. Methods: In the first trial, serial dilutions of recombinant HRP2 antigen were tested on an HRP2-detectiing RDT. In a second trial, serial dilutions of culture-derived Plasmodium falciparum parasites were tested against three HRP2-detecting RDTs. Results: A prozone-like effect occurred in RDTs at a high concentration of the target antigen, histidine-rich protein-2 (above 15,000 ng/ml), a level that corresponds to more than 312000 parasites per μL. Similar results were noted on three RDT products using dilutions of cultured parasites up to a parasite density of 25%. While reduced line intensity was observed, no false negative results occurred. Conclusions: These results suggest that false-negative malaria RDT results will rarely occur due to a prozone-like effect in high-density infections, and other causes are more likely. However, RDT line intensity is poorly indicative of parasite density in high-density infections and RDTs should, therefore, not be considered quantitative. Immediate management of suspected severe malaria should rely on clinical assessment or microscopy. Evaluation against high concentrations of antigen should be considered in malaria RDT product development and lot-release testing, to ensure that very weak or false negative results will not occur at antigen concentrations that might be seen clinically.
- Open Access
- 8 February 2011
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1) , 30
Blood transfer devices for malaria rapid diagnostic tests: evaluation of accuracy, safety and ease of use
Malaria rapid diagnostic tests (RDTs) are increasingly used by remote health personnel with minimal training in laboratory techniques. RDTs must, therefore, be as simple, safe and reliable as possible. Transfer of blood from the patient to the RDT is critical to safety and accuracy, and poses a significant challenge to many users. Blood transfer devices were evaluated for accuracy and precision of volume transferred, safety and ease of use, to identify the most appropriate devices for use with RDTs in routine clinical care.
- 8 February 2011
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1) , 30
Open AccessBlood transfer devices for malaria rapid diagnostic tests: evaluation of accuracy, safety and ease of use
Malaria rapid diagnostic tests (RDTs) are increasingly used by remote health personnel with minimal training in laboratory techniques. RDTs must, therefore, be as simple, safe and reliable as possible. Transfer of blood from the patient to the RDT is critical to safety and accuracy, and poses a significant challenge to many users. Blood transfer devices were evaluated for accuracy and precision of volume transferred, safety and ease of use, to identify the most appropriate devices for use with RDTs in routine clinical care.